Our amended and restated certificate of incorporation authorizes the issuance of 2,000,000,000 shares of Class A common stock, $0.001 par value per share, and 300,000,000 shares of Class B common stock, $0.001 par value per share. Class A and Class B common stock are referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted.

In February 2024, our Board of Directors authorized a stock repurchase program of up to $1.5 billion of our Class A common stock. In November 2024, our Board of Directors authorized the repurchase of an additional $1.2 billion of our outstanding Class A common stock. In November 2025, our Board of Directors authorized the repurchase of an additional $1.0 billion of our outstanding Class A common stock. Repurchases of our Class A common stock may be effected from time to time, either on the open market (including preset trading plans), in privately negotiated transactions, and other transactions in accordance with applicable securities laws. The repurchase program, which has no expiration date, does not obligate us to repurchase any specific number of shares and may be discontinued at any time.

During the three months ended April 30, 2026, we repurchased and subsequently retired 4,169,208 shares of our Class A common stock for an aggregate amount of $361.7 million. As of April 30, 2026, $625.0 million of the repurchase authorization remained available.

In May 2026, our Board of Directors authorized the repurchase of an additional $1.0 billion of our outstanding Class A common stock, under our existing repurchase program.

We have two equity incentive plans: the 2011 Global Share Plan (“2011 Plan”) and the 2019 Equity Incentive Plan (“2019 Plan”). All shares that remain available for future grants are under the 2019 Plan.


	Stock Options
	Outstanding Stock Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value

	(in thousands, except share, life, and per share data)
Balance as of January 31, 2026	1,542,753	$	11.81	2.2	$	124,080
Exercised	(248,640)	$2.03			$	19,837
Canceled/forfeited/expired	—	$	—
Outstanding and exercisable as of April 30, 2026	1,294,113	$13.69		2.2	$	108,007


	RSUs
	RSUs	Weighted- Average Grant Date Fair Value Per Share
Unvested as of January 31, 2026	20,106,305	$	75.51
Granted	5,217,795	$	82.69

Vested	(2,642,984)	$	74.63
Canceled/forfeited	(818,494)	$	75.86
Unvested as of April 30, 2026	21,862,622	$	77.32

As of April 30, 2026, unrecognized stock-based compensation expense related to RSUs was $1,585.6 million, which is expected to be recognized over a weighted-average period of 3.0 years.

In April 2019, we adopted the 2019 Employee Stock Purchase Plan (“ESPP”). As of April 30, 2026, unrecognized stock-based compensation expense related to the ESPP was $9.4 million, which is expected to be recognized over a weighted-average period of 1.1 years.


	Three Months Ended April 30,
	2026		2025

	(in thousands)
Cost of revenue	$	20,963	$	27,427
Research and development	71,026		72,936
Sales and marketing	58,039		68,433
General and administrative	28,925		32,773
Total stock-based compensation expense	$	178,953	$	201,569
Benefit from income taxes	(33,697)		(38,161)
Total stock-based compensation expense recorded to net income	$	145,256	$	163,408